HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia

Mostrar otras versiones (1)

BACKGROUND: The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and low-risk endometrial hyperplasia. METHODS: Endometrial biopsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ørbo, Anne, Arnes, Marit, Lyså, Lena Myreng, Borgfelt, Christer, Straume, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023780/
https://www.ncbi.nlm.nih.gov/pubmed/27537387
http://dx.doi.org/10.1038/bjc.2016.247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023780/
https://www.ncbi.nlm.nih.gov/pubmed/27537387
http://dx.doi.org/10.1038/bjc.2016.247

Ejemplares similares